Treating Blood Cancers
CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL
Recorded on May 28, 2026
Tara Gregory, MD
President
Colorado Blood Cancer Institute
Denver, CO
Jay Spiegel, MD
Assistant Professor
Division of Transplant and Cellular Therapy
University of Miami Sylvester Comprehensive Cancer Center
Miami, FL
In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma...
Optimizing HSCT in Blood Cancers
Lori Muffly MD, MS, Stanford Medicine, Stanford, CA
Recorded on May 12, 2026
Lori Muffly MD, MS
Professor of Medicine
Division of Blood and Marrow Transplantation & Cellular Therapy
Stanford Medicine
Stanford, CA
In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams...
Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Recorded on April 23, 2026
Mayra Allen, PhD
Clinical Psychologist, Psycho-Oncology Service
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The di...
Driving Progress in AML
David Sallman, MD, Moffitt Cancer Center, Tampa, FL
Recorded on April 9, 2026
David Sallman, MD
Associate Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in...
Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA
Recorded on March 30, 2026
Matthew Loscalzo, LCSW, APOS Fellow
Founding Executive Director and Professor Emeritus of Supportive Care Medicine
and Professor of Population Sciences
City of Hope
Duarte, CA
In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals often define “normal” differently after treatment. He discusses the emotional shifts that impact relationships, work, and future planning, and shares how healthcare professionals can support meaningful conversations and shared decision-making after treatment ends. Tune in to h...
Optimizing Outcomes in Myeloma
Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC
Recorded on March 10, 2026
Amy Pierre, MSN, ANP-BC
Senior Clinical Director, Research Oncology, Flatiron Health
Nurse Practitioner, Memorial Sloan Kettering Cancer Center
New York, NY
Peter Voorhees, MD
Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder
Program, Department of Hematologic Oncology and Blood Disorders
Levine Cancer Institute
Charlotte, NC
Professor, Cancer Medicine
Wake Forest University School of Medicine
Winston-Salem, NC
...
Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology
Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC
Recorded on February 19, 2026
Matthew Kutny, MD
Professor of Pediatrics
Director, Leukemia, Lymphoma and Histiocytosis Program
Director, Pediatric Clinical Trials Office
Institutional Principal Investigator, Children’s Oncology Group (NCI NCTN)
Pediatric Hematology and Oncology
University of Alabama at Birmingham
Birmingham, AL
Julie Guillot
Pediatric AML parent, global advocate, and Blood Cancer United Volunteer
What’s New and What’s Next in CLL
Brad Kahl, MD, Siteman Cancer Center, St. Louis MO
Recorded on January 27, 2026
Brad Kahl, MD
Professor of Medicine
Division of Oncology, Department of Medicine
Washington University School of Medicine
Director, Lymphoma Program
Siteman Cancer Center
St. Louis, MO
In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman Cancer Center in St. Louis, Missouri, as he delivers a concise and practical overview of chronic lymphocytic leukemia (CLL), from initial disease presentation to key diagnostic considerations. Dr. Kahl discusses the prognostic value...
Guiding Fertility Care for Adolescents and Young Adults
Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA
Recorded on January 20, 2026
Pam Simon, MSN, CPNP, CPON
Nurse Practitioner & Program Manager
Stanford Adolescent and Young Adult Cancer Program (SAYAC)
Palo Alto, CA
H. Irene Su, MD MSCE
Professor
Reproductive Endocrinology and Infertility Fellowship Director
Division of Reproductive Endocrinology and Infertility
Co-Director, Center for Obstetrics and Gynecology Research Innovations
Department of Obstetrics, Gynecology and...
Building Resilience: Burnout & Compassion Fatigue Tools for HCPs
Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT
Recorded on January 8, 2026
Chelsey Winegar, LCSW, MBA
Manager of Oncology Services
Intermountain Health
Murray, UT
Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences between burnout and compassion fatigue, and why understanding both is essential for the well being of healthcare professionals and the patients they serve. Chelsey shares practical strategies for recognizing early warning signs, monitoring staff wellness, and building supportive, stigma free environments. The episode also hi...
Key Insights from Attending ASH 2025
Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC
Recorded on December 18, 2025
Lore Gruenbaum, PhD
Chief Scientific Officer & Senior Vice President of Research
Blood Cancer United
Washington, DC
Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the...
Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
Raymond Mailhot, MD, MPH, University of Miami, Miami, FL
Recorded on December 2, 2025
Raymond Mailhot, MD, MPH
Department of Radiation Oncology
University of Miami
Miami, FL
Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune...
Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
Paul J. Hampel, MD, Mayo Clinic, Rochester, MN
Recorded on November 4, 2025
Paul J. Hampel, MD
Assistant Professor of Medicine
Division of Hematology, Department of Medicine
Mayo Clinic
Rochester, MN
In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to i...
Managing CML: What HCPs Need to Know
Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on October 23, 2025
Michael J. Mauro, MD
Director, Chronic Myeloid Leukemia Program
Professor of Medicine, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY
Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy...
Understanding MRD: Insights for clinical practice and patient care
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA
Recorded on September 25, 2025
Rahul Banerjee, MD, FACP
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA
In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for te...
Pediatric Acute Leukemias: Focus on clinical trials for treatment
Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Recorded on September 9, 2025
Ann Collins, PA
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC
Kelly Laschinger, MSN, RN, CPNP, CPHON
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC
Sarah K. Tasian, MD
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of...
Charting the Course of ALL: From Diagnosis to Advances
Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA
Recorded on June 27, 2025
Catherine Lai, MD, MPH
Associate Professor
Physician Leader, Leukemia Clinical Research Unit
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA
In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for Advanced Medicine, joins us to discuss the current landscape of adult acute lymphoblastic leukemia (ALL) treatment. She highlights recent advances in frontline and relapsed therapies, the critical role of measurable residual disease (MRD), and th...
Strategies and Advances in AML
Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH
Recorded on May 27, 2025
Uma Borate, MBBS, MS
Associate Professor, Division of Hematology
Acute Leukemia Clinical Research Disease Group Leader
The Ohio State University
Columbus, OH
What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, Ohio, as she dives into emerging breakthroughs in AML biology, including molecular drivers, menin inhibitors, and the challenges of developing bispecifics and CAR T-cell therapies. She also shares updates from the LLS Beat AML® Mas...
Advancing Care in Myeloproliferative Neoplasms (MPNs)
Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH
Recorded on May 13, 2025
Aaron Gerds, MD, MS
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University School of Medicine
Medical Director
Case Comprehensive Cancer Center Clinical Research Office
Cleveland, OH
In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side...
A Collaborative Approach to Survivorship Care
A Collaborative Approach to Survivorship Care
Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY
…A Collaborative Approach to Survivorship CareRead More »
MDS: Patient-Centered Approaches to Diagnosis and Treatment
Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Recorded on April 17, 2025
Mikkael A. Sekeres, MD, MS
Chief, Division of Hematology
Professor of Medicine
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and...
Optimizing Care for Pediatric Blood Cancer
Jeffrey Magee, MD, PhD, Washington University School of Medicine, St. Louis, MO
Recorded on April 3, 2025
Jeffrey Magee, MD, PhD
Elizabeth H. and James S. McDonnell III Professor of Pediatrics
Director, McDonnell Pediatric Cancer Center
Division of Pediatric Hematology and Oncology
Washington University School of Medicine
St. Louis, MO
In this episode, we sit down with Dr. Jeffrey Magee from the McDonald Pediatric Cancer Center at the Washington University School of Medicine in St. Louis to discuss the evolving landscape of pediatric blood cancers. Reflecting on his work...
Navigating Complex and Challenging Cases in Myeloma
Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN
Recorded on March 18, 2025
Angela Dispenzieri, MD
Consultant, Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory
Medicine and Pathology
Mayo Clinic
Rochester, MN
Join us as we dive into in the complex care of amyloid and myeloma with Dr. Angela Dispenzieri from Mayo Clinic Rochester, Minnesota. She explains the diagnosis and explores the differences between amyloid and myeloma. Discussion on treatment strategies for complex cases, side effects of therapies, and difficult conversations with patients...
Beyond Burnout: Strategies for Empowering Healthcare Professionals
Guy Maytal, MD, Forge Health and Weill Cornell Medicine, New York
Recorded on February 20, 2025
Guy Maytal, MD
Chief Medical Officer, Forge Health
White Plains, NY
Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine
New York, NY
In this episode, Dr. Guy Maytal, from Forge Health and Weill Cornell Medicine in New York, explores burnout and wellness in healthcare professionals, highlighting the difference between burnout and compassion fatigue. He shares valuable insights on recognizing these issues, while emphasizing the importance of connection, resilience, and self-care in preventing and overcoming...
Key Strategies for HCPs: Supporting Caregivers and Care Partners
Timothy Pearman, PhD, ABPP, Northwestern University Feinberg School of Medicine, Chicago, IL
Recorded on February 6, 2025
Timothy Pearman, PhD, ABPP
Director, Supportive Oncology
Robert H. Lurie Comprehensive Cancer Center
Professor, Department of Medical Social Sciences and Psychiatry & Behavioral Sciences
Northwestern University Feinberg School of Medicine
Chicago, IL
Join us for an insightful episode featuring Dr. Timothy Pearman from Northwestern University, as he explores the critical role of caregivers and care partners to a patient’s healthcare team. Dr. Pearman discusses the challenges caregivers face, including burnout, relationship stress, an...
CAR-T in 2025: Advancements and the Road Ahead
Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX
Recorded on January 21, 2025
Jason Westin, M.D., MS, FACP
Professor, Department of Lymphoma & Myeloma
Lead, Lymphoma & Myeloma Service Line
Director, Lymphoma Clinical Research
Section Chief, Aggressive and Indolent Lymphoma
MD Anderson Cancer Center
Houston, TX
In this episode, Dr. Jason Westin from MD Anderson Cancer Center in Houston, Texas explores CAR T-cell therapy, covering both current and emerging indications. He highlights the educational needs of patients and caregivers, as well as the essential role...
Exploring Cutaneous T-Cell Lymphoma
Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL
Recorded on January 7, 2025
Jaehyuk (Jae) Choi, MD
Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine
Chicago, IL
In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma (CTCL), covering key diagnostic tools, emerging therapies, and the importance of a multidisciplinary team approach. He delves into effective symptom management, including the psychosocial impact of pruritus, and discusses the latest ongoing research. Additionally, Dr. Choi...
Highlights from Attending ASH 2024
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on December 19, 2024
Lee Greenberger, PhD
Chief Scientific Officer and SVP
The Leukemia & Lymphoma Society
Rye Brook, NY
In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today!
This...
Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL
Recorded on November 21, 2024
Celeste Bello, MD
Senior Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!
Understanding Mental Health in Cancer Survivorship
Understanding Mental Health in Cancer Survivorship
Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN
Recorded on November 14, 2024
Lynn Gooden, BSN, RN, ONN-CG
Oncology Navigation and Survivorship Manager
Oncology Navigation
Community Health Network MD Anderson Cancer Center
Indianapolis, IN
Cassie Osborne, MSN, RN, OCN, ONN-CG
Oncology Nurse Navigator
Oncology Navigation-Hematology/Sarcoma/Brain/Skin
Community Health Network MD Anderson Cancer Center
Indianapolis...
What’s New in Chronic Lymphocytic Leukemia (CLL)?
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH
Recorded on October 29, 2024
Kerry A. Rogers, MD
Associate Professor
Division of Hematology
The Ohio State University
Columbus, OH
Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies...
The Role of the Healthcare Team in Biomarker Testing
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT
Recorded on July 2, 2024
Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future...
Decoding Medicare for Healthcare Professionals
Recorded on September 20, 2024
Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by th...
Treating Hodgkin Lymphoma: What HCPs Need to Know
Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA
Recorded on June 27, 2024
Alex F. Herrera, MD
Associate Professor
Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation
Associate Medical Director, Briskin Center for Clinical Research & City of Hope
Duarte Clinical Trials Office
City of Hope Medical Center
Duarte, CA
In this episode, Dr. Alex Herrera from City of Hope explores the intricacies of Hodgkin lymphoma, from diagnosis and monitoring techniques to treatment goals and options. He discusses emerging therapies, including the significance...
Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting
Recorded on September 9, 2024
Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Shira Dinner, from Northwestern University, and Dr. Tom Martin, from University of California San Francisco, about their insights and key takeaways from the conference. Learn more by tuning in here!<...
Unpacking Mantle Cell Lymphoma
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA
Recorded on June 6, 2024
Krish Patel, MD
Director, Lymphoma Program
Director, Hematologic Malignancies and Cellular Therapy
Swedish Cancer Institute
Seattle, WA
Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on...
Clinical Perspectives on Hereditary Myeloid and Hematologic Disorders
Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA
Recorded on June 4, 2024
Ximena Jordan-Bruno, MD
Assistant Professor, Division of Hematology/Oncology
University of Pennsylvania
Philadelphia, PA
Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition syndromes. Learn about key clinical features, diagnostic approaches, the role of genetic counseling, and future research directions. Tune in today for valuable updates to enhance your understanding and practice! Feedback
Navigating Adult Survivorship Care
Susan Hong, MD, Virginia Commonwealth University, Richmond, VA
Recorded on May 21, 2024
Susan Hong, MD
Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center
Associate Professor, School of Medicine Internal Medicine
Virginia Commonwealth University
Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University’s Massey Cancer Center, discusses survivorship care in adults. She explores the intersection of healthcare professional and patient goals in survivorship care, as well as disparities and challenges impacting access and follow-up. Dr. Hong offers strategies to improve adherence to survivorship ca...
Managing Oral and Dental Complications in Cancer Treatment
David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA
Recorded on April 25, 2024
David Dean, DDS, MSD, DABOM, FDS RCSEd
Director, Oral Medicine
Fred Hutchinson Cancer Center
Clinical Associate Professor
University of Washington School of Dentistry
Seattle, WA Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that...
Exploring Survivorship Needs of Older Adults
Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY
Recorded on April 16, 2024
Cesar Rodriguez, MD
Associate Professor of Medicine, Tisch Cancer Institute
Clinical Director, Multiple Myeloma Center of Excellence
Mount Sinai Hospital
New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider’s role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of...
